Niall Tubridy

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Gait and balance impairment in early multiple sclerosis in the absence of clinical disability

C. López Martin, Beverley A. Phillips, Trevor J. Kilpatrick et al. · Multiple Sclerosis Journal · 2006 · 531 citations

Gait Analysis, Physical Activity, Neurological Disorder +22

CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis

Jean M. Fletcher, Róisín Lonergan, Lisa Costelloe et al. · The Journal of Immunology · 2009 · 467 citations · Full text

T-regulatory Cell, Immune Regulation, Immunology +19

The effect of anti-α4 integrin antibody on brain lesion activity in MS

Niall Tubridy, P. O. Behan, Rudy Capildeo et al. · Neurology · 1999 · 308 citations

Attitudes of US medical trainees towards neurology education: "Neurophobia" - a global issue

Andrey Zinchuk, Eoin P. Flanagan, Niall Tubridy et al. · BMC Medical Education · 2010 · 224 citations · Full text